MARGINAL ZONE LYMPHOMA(MZL)
Clinical trials for MARGINAL ZONE LYMPHOMA(MZL) explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE LYMPHOMA(MZL) trials appear
Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA(MZL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo tackles rare eye cancer
Disease control OngoingThis study tests a new drug (orelabrutinib) combined with either low-dose radiation or another drug (rituximab) for a rare type of eye lymphoma called ocular adnexal MALT lymphoma. About 39 adults with early-stage disease who haven't had prior treatment will participate. The goal…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 03, 2026 22:07 UTC
-
Watch and wait or worry and wait? new study probes hidden toll of lymphoma monitoring
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how the 'watch and wait' approach affects the quality of life of 250 Korean adults with slow-growing lymphomas like CLL or follicular lymphoma. Researchers want to find out if waiting without treatment causes anxiety or worry. Participants will fill out questi…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC